Clinical Trial Update: A Controlled Study of Olanzapine in Children With Autism [Phase 2]

View source ↗

Summary

This clinical trial update indicates the completion of a Phase 2, controlled study of olanzapine in children with autism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• olanzapine (olanzapine)

Snippet

Sponsor: FDA Office of Orphan Products Development | Conditions: Autistic Disorder | Phase 2 | Status: COMPLETED